Hyperphagia in short bowel patients: Fat-free mass is a strong predictor.


Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
06 2019
Historique:
received: 20 08 2018
revised: 10 12 2018
accepted: 29 12 2018
pubmed: 20 3 2019
medline: 2 9 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Some patients with short bowel syndrome (SBS) develop hyperphagic behavior. Such an increase in food intake stimulates intestinal adaptation and limits dependence on parenteral nutrition (PN). The aim of this study was to determine the factors modulating food consumption in patients with SBS. The associations between oral energy intake (OEI) and anthropometric, metabolic, nutritional, and intestinal absorption-related characteristics were determined in a monocentric cohort of patients with SBS on PN with a stable nutritional status. Body composition was assessed by dual x-ray absorptiometry. Data were retrospectively collected from clinical records. After screening, 38 adult patients with a SBS on PN were included in this study. OEI ranged from 577 to 4054kcal/d. OEI correlated positively with weight, fat-free mass, handgrip strength, and resting energy expenditure (REE) and negatively with free triiodothyronine and C-reactive protein using Spearman correlation. Fat-free mass and thyroid-stimulating hormone remained positively correlated with OEI independently of all other parameters in a multilinear regression model. Fat-free mass is a strong predictor of OEI in patients with SBS on PN and without debilitating gastrointestinal symptoms. Increasing fat-free mass could be a way to stimulate OEI in these patients. Further studies are needed to assess this assumption.

Identifiants

pubmed: 30889456
pii: S0899-9007(18)30720-2
doi: 10.1016/j.nut.2018.12.013
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-151

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Cécile Bétry (C)

The Medical School, University of Nottingham, Nottingham, UK; Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France. Electronic address: cbetry@chu-grenoble.fr.

Madeleine Lauverjat (M)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France.

Thomas Mouillot (T)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France; CHU François Mitterrand, Bourgogne-Franche Comté, Dijon, France.

Charlotte Bergoin (C)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France.

Didier Barnoud (D)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France.

Sabrina Ait (S)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France.

Cécile Chambrier (C)

Unité de nutrition clinique intensive, Hospices Civils de Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH